1-9 of 9
Galen Hostetter
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Nuclear PTEN Localization Contributes to DNA Damage Response in Endometrial Adenocarcinoma and Could Have a Diagnostic Benefit for Therapeutic Management of the Disease

Free
Ananda Mukherjee, Amanda L. Patterson, Jitu W. George, Tyler J. Carpenter, Zachary B. Madaj, Galen Hostetter, John I. Risinger, Jose M. Teixeira
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (9): 1995–2003.
https://doi.org/10.1158/1535-7163.MCT-17-1255
Published: 04 September 2018
View articletitled, Nuclear PTEN Localization Contributes to DNA Damage Response in Endometrial Adenocarcinoma and Could Have a Diagnostic Benefit for Therapeutic Management of the Disease
Open the PDF for Nuclear PTEN Localization Contributes to DNA Damage Response in Endometrial Adenocarcinoma and Could Have a Diagnostic Benefit for Therapeutic Management of the Disease in another window
Includes: Supplementary data
Journal Articles

Abstract B50: Targeting KRASG12D colorectal cancer with combined inhibition of PI3K/mTOR and MAPK signaling

Free
Danielle Burgenske, David Monsma, Dawna Dylewski, Stephanie Scott, Aaron Sayfie, Donald Kim, Martin Luchtefeld, Katie Martin, Paul Stephenson, Galen Hostetter, Nadav Dujovny, Jeffrey MacKeigan
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (7_Supplement): B50.
https://doi.org/10.1158/1538-8514.PI3K14-B50
Published: 06 July 2015
View articletitled, Abstract B50: Targeting KRASG12D colorectal cancer with combined inhibition of PI3K/mTOR and MAPK signaling
Journal Articles

Abstract A183: Whole-genome sequencing to find potential targets for therapy in patients with refractory K-ras mutated metastatic colorectal cancer.

Free
Ramesh K. Ramanathan, Viji Shanmugam, Shripad Sinari, Manpreet Chadha, Winnie Liang, Tyler Izatt, Alexis Christoforides, Hollie Benson, Lori Phillips, Angela Baker, Galen Hostetter, Daniel Von Hoff, David Craig, John Carpten
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (11_Supplement): A183.
https://doi.org/10.1158/1535-7163.TARG-11-A183
Published: 12 November 2011
View articletitled, Abstract A183: Whole-genome sequencing to find potential targets for therapy in patients with refractory K-ras mutated metastatic colorectal cancer.
Journal Articles

Radiosensitization and Stromal Imaging Response Correlates for the HIF-1 Inhibitor PX-478 Given with or without Chemotherapy in Pancreatic Cancer

Free
David L. Schwartz, James A. Bankson, Robert Lemos, Jr., Stephen Y. Lai, Arun K. Thittai, Yi He, Galen Hostetter, Michael J. Demeure, Daniel D. Von Hoff, Garth Powis
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2010) 9 (7): 2057–2067.
https://doi.org/10.1158/1535-7163.MCT-09-0768
Published: 07 July 2010
View articletitled, Radiosensitization and Stromal Imaging Response Correlates for the HIF-1 Inhibitor PX-478 Given with or without Chemotherapy in Pancreatic Cancer
Open the PDF for Radiosensitization and Stromal Imaging Response Correlates for the HIF-1 Inhibitor PX-478 Given with or without Chemotherapy in Pancreatic Cancer in another window
Journal Articles

Abstract B194: Enhanced antitumor activity of the HIF‐1 inhibitor PX‐478 combined with radiation and chemotherapy in pancreatic cancer

Free
Garth Powis, Daniel Von Hoff, James Bankson, Robert Iemos, Galen Hostetter, Michael Demeure, David Schwartz
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): B194.
https://doi.org/10.1158/1535-7163.TARG-09-B194
Published: 10 December 2009
View articletitled, Abstract B194: Enhanced antitumor activity of the HIF‐1 inhibitor PX‐478 combined with radiation and chemotherapy in pancreatic cancer
Journal Articles

Abstract A30: Integrated analysis of genomic data and annotations in cancer research

Free
Carolyn V. Ustach, Haiyong Han, Seungchan Kim, Galen Hostetter, Caroline H. Diep, Manuel Hidalgo, Michael Barret, Johnathan J. Keats, Daniel Von Hoff, Christopher Kingsley
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): A30.
https://doi.org/10.1158/1535-7163.TARG-09-A30
Published: 10 December 2009
View articletitled, Abstract A30: Integrated analysis of genomic data and annotations in cancer research
Journal Articles

Abstract B170: Downregulation of Yes‐associated protein 1 (YAP1) expression reduces cell proliferation and clonogenicity of pancreatic cancer cells

Free
Caroline H. Diep, Kelly Zucker, Aprill Watanabe, Galen Hostetter, Ruben Munoz, Daniel D. Von Hoff, Haiyong Han
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): B170.
https://doi.org/10.1158/1535-7163.TARG-09-B170
Published: 10 December 2009
View articletitled, Abstract B170: Downregulation of Yes‐associated protein 1 (YAP1) expression reduces cell proliferation and clonogenicity of pancreatic cancer cells
Journal Articles

Gene expression profiling-based identification of cell-surface targets for developing multimeric ligands in pancreatic cancer

Free
Yoganand Balagurunathan, David L. Morse, Galen Hostetter, Vijayalakshmi Shanmugam, Phillip Stafford, Sonsoles Shack, John Pearson, Maria Trissal, Michael J. Demeure, Daniel D. Von Hoff, Victor J. Hruby, Robert J. Gillies, Haiyong Han
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2008) 7 (9): 3071–3080.
https://doi.org/10.1158/1535-7163.MCT-08-0402
Published: 11 September 2008
View articletitled, Gene expression profiling-based identification of cell-surface targets for developing multimeric ligands in pancreatic cancer
Open the PDF for Gene expression profiling-based identification of cell-surface targets for developing multimeric ligands in pancreatic cancer in another window
Includes: Supplementary data
Journal Articles

Small interfering RNA-mediated knockdown of PRL phosphatases results in altered Akt phosphorylation and reduced clonogenicity of pancreatic cancer cells

Free
Bret Stephens, Haiyong Han, Galen Hostetter, Michael J. Demeure, Daniel D. Von Hoff
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2008) 7 (1): 202–210.
https://doi.org/10.1158/1535-7163.MCT-07-0542
Published: 17 January 2008
View articletitled, Small interfering RNA-mediated knockdown of PRL phosphatases results in altered Akt phosphorylation and reduced clonogenicity of pancreatic cancer cells
Open the PDF for Small interfering RNA-mediated knockdown of PRL phosphatases results in altered Akt phosphorylation and reduced clonogenicity of pancreatic cancer cells in another window